Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.
作者信息
Crispin Max, Yu Xiaojie, Bowden Thomas A
机构信息
Department of Biochemistry, Oxford Glycobiology Institute, University of Oxford, Oxford OX1 3QU, United Kingdom.
出版信息
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3544-6. doi: 10.1073/pnas.1310657110. Epub 2013 Aug 8.
Abstract
摘要
相似文献
1
Crystal structure of sialylated IgG Fc: implications for the mechanism of intravenous immunoglobulin therapy.唾液酸化IgG Fc的晶体结构：对静脉注射免疫球蛋白治疗机制的启示
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3544-6. doi: 10.1073/pnas.1310657110. Epub 2013 Aug 8.
2
Reply to Crispin et al.: Molecular model that accounts for the biological and physical properties of sialylated Fc.对克里斯平等人的回复：解释唾液酸化Fc生物学和物理特性的分子模型。
Proc Natl Acad Sci U S A. 2013 Sep 17;110(38):E3547. doi: 10.1073/pnas.1311721110.
3
General mechanism for modulating immunoglobulin effector function.调节免疫球蛋白效应功能的一般机制。
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9868-72. doi: 10.1073/pnas.1307864110. Epub 2013 May 22.
4
DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells.DC-SIGN与α2,6-唾液酸化IgG Fc的相互作用对于静脉注射免疫球蛋白对人树突状细胞的抗炎活性而言并非必需。
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):E24; author reply E25. doi: 10.1073/pnas.0900016106. Epub 2009 Feb 23.
5
A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs.IgG Fc 聚糖的新作用：唾液酸化 IgG Fc 的抗炎活性。
J Clin Immunol. 2010 May;30 Suppl 1:S9-14. doi: 10.1007/s10875-010-9405-6.
6
Identification of a receptor required for the anti-inflammatory activity of IVIG.鉴定静脉注射免疫球蛋白抗炎活性所需的一种受体。
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19571-8. doi: 10.1073/pnas.0810163105. Epub 2008 Nov 26.
7
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?静脉注射免疫球蛋白治疗：IgG 如何调节免疫系统？
Nat Rev Immunol. 2013 Mar;13(3):176-89. doi: 10.1038/nri3401. Epub 2013 Feb 15.
8
Intravenous gammaglobulin suppresses inflammation through a novel T(H)2 pathway.静脉注射丙种球蛋白通过一种新的 TH2 途径抑制炎症反应。
Nature. 2011 Jun 19;475(7354):110-3. doi: 10.1038/nature10134.
9
Human DC-SIGN and CD23 do not interact with human IgG.人 DC-SIGN 和 CD23 与 IgG 不相互作用。
Sci Rep. 2019 Jul 10;9(1):9995. doi: 10.1038/s41598-019-46484-2.
10
Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.剖析 IVIg 治疗的分子机制：血清 IgG 与 DC-SIGN 的相互作用不依赖于抗体糖型或 Fc 结构域。
J Mol Biol. 2013 Apr 26;425(8):1253-8. doi: 10.1016/j.jmb.2013.02.006. Epub 2013 Feb 13.
引用本文的文献
1
The importance of IgG glycosylation-What did we learn after analyzing over 100,000 individuals.IgG糖基化的重要性——在分析了超过10万人之后我们学到了什么。
Immunol Rev. 2024 Nov;328(1):143-170. doi: 10.1111/imr.13407. Epub 2024 Oct 4.
2
Immunomodulatory and anti-inflammatory properties of immunoglobulin G antibodies.免疫球蛋白G抗体的免疫调节和抗炎特性。
Immunol Rev. 2024 Nov;328(1):372-386. doi: 10.1111/imr.13404. Epub 2024 Sep 27.
3
A monoclonal antibody targeting the Nipah virus fusion glycoprotein apex imparts protection from disease.一种针对尼帕病毒融合糖蛋白顶端的单克隆抗体赋予了对疾病的保护作用。
J Virol. 2024 Oct 22;98(10):e0063824. doi: 10.1128/jvi.00638-24. Epub 2024 Sep 6.
4
The role of antibody glycosylation in autoimmune and alloimmune kidney diseases.抗体糖基化在自身免疫和同种免疫性肾脏疾病中的作用。
Nat Rev Nephrol. 2024 Oct;20(10):672-689. doi: 10.1038/s41581-024-00850-0. Epub 2024 Jul 3.
5
Serum immunoglobulin and the threshold of Fc receptor-mediated immune activation.血清免疫球蛋白和 Fc 受体介导的免疫激活阈值。
Biochim Biophys Acta Gen Subj. 2023 Nov;1867(11):130448. doi: 10.1016/j.bbagen.2023.130448. Epub 2023 Aug 29.
6
Polyfunctional antibodies: a path towards precision vaccines for vulnerable populations.多功能抗体：为脆弱人群开发精准疫苗的途径。
Front Immunol. 2023 Jun 27;14:1183727. doi: 10.3389/fimmu.2023.1183727. eCollection 2023.
7
Bivalent non-human gal-α1-3-gal glycan epitopes in the Fc region of a monoclonal antibody model can be recognized by anti-Gal-α1-3-Gal IgE antibodies.双价非人类半乳糖-α1-3-半乳糖聚糖表位在单克隆抗体模型的 Fc 区域可被抗-Gal-α1-3-Gal IgE 抗体识别。
MAbs. 2023 Jan-Dec;15(1):2239405. doi: 10.1080/19420862.2023.2239405.
8
Effect of posttranslational modifications and subclass on IgG activity: from immunity to immunotherapy.翻译后修饰及亚类对IgG活性的影响：从免疫到免疫治疗
Nat Immunol. 2023 Aug;24(8):1244-1255. doi: 10.1038/s41590-023-01544-8. Epub 2023 Jul 6.
9
Analysis and validation of overall N-glycan conformation in Privateer.分析和验证 Privateer 中整体 N-糖链构象。
Acta Crystallogr D Struct Biol. 2023 Jun 1;79(Pt 6):462-472. doi: 10.1107/S2059798323003510. Epub 2023 May 23.
10
Glycobiology of rheumatic diseases.风湿性疾病的糖生物学。
Nat Rev Rheumatol. 2023 Jan;19(1):28-43. doi: 10.1038/s41584-022-00867-4. Epub 2022 Nov 23.
本文引用的文献
1
General mechanism for modulating immunoglobulin effector function.调节免疫球蛋白效应功能的一般机制。
Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9868-72. doi: 10.1073/pnas.1307864110. Epub 2013 May 22.
2
Dissecting the molecular mechanism of IVIg therapy: the interaction between serum IgG and DC-SIGN is independent of antibody glycoform or Fc domain.剖析 IVIg 治疗的分子机制：血清 IgG 与 DC-SIGN 的相互作用不依赖于抗体糖型或 Fc 结构域。
J Mol Biol. 2013 Apr 26;425(8):1253-8. doi: 10.1016/j.jmb.2013.02.006. Epub 2013 Feb 13.
3
Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis.在聚糖生物合成过程中捕获的抗体折叠中间体的化学和结构分析。
J Am Chem Soc. 2012 Oct 24;134(42):17554-63. doi: 10.1021/ja306068g. Epub 2012 Oct 15.
4
NMR characterization of immunoglobulin G Fc glycan motion on enzymatic sialylation.基于酶法唾液酸化的免疫球蛋白 G Fc 聚糖构象的 NMR 特征分析。
Biochemistry. 2012 Jun 5;51(22):4618-26. doi: 10.1021/bi300319q. Epub 2012 May 22.
5
Identification of a receptor required for the anti-inflammatory activity of IVIG.鉴定静脉注射免疫球蛋白抗炎活性所需的一种受体。
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19571-8. doi: 10.1073/pnas.0810163105. Epub 2008 Nov 26.
Zotero 插件